title: Oral vs intravenous tacrolimus-based induction therapy in renal transplantation.
authors.affiliation: Department of Surgery III, Tokyo Women's Medical University, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Tojimbara
authors.forename: M
authors.initials: M
authors.lastname: Kimikawa
authors.forename: I
authors.initials: I
authors.lastname: Nakajima
authors.forename: S
authors.initials: S
authors.lastname: Sato
authors.forename: M
authors.initials: M
authors.lastname: Nakamura
authors.forename: H
authors.initials: H
authors.lastname: Ishida
authors.forename: K
authors.initials: K
authors.lastname: Tanabe
authors.forename: I
authors.initials: I
authors.lastname: Koyama
authors.forename: K
authors.initials: K
authors.lastname: Utsumi
authors.forename: A
authors.initials: A
authors.lastname: Sannomiya
authors.forename: K
authors.initials: K
authors.lastname: Tsuji
authors.forename: S
authors.initials: S
authors.lastname: Fuchinoue
authors.forename: T
authors.initials: T
authors.lastname: Agishi
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D007262:Infusions, Intravenous; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011446:Prospective Studies; D012263:Ribonucleosides / Q000627:therapeutic use; D016559:Tacrolimus / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D003404:Creatinine; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone